Tonix Pharmaceuticals Holding Corp (TNXP) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −1,41%	1 076,13	−15,38	−1,41%	—	1 091,51	1 090,40	1 090,40	1 073,69	—	—
SIXC Communications SIXC Communications	SIXC −0,55%	606,74	−3,37	−0,55%	—	610,11	610,11	610,29	606,17	—	—
SIXE Energy SIXE Energy	SIXE +0,88%	1 248,82	+10,84	+0,88%	—	1 237,98	1 237,83	1 252,41	1 225,03	—	—
SIXI Industrials SIXI Industrials	SIXI −1,17%	1 724,36	−20,35	−1,17%	—	1 744,71	1 740,95	1 747,29	1 721,57	—	—
SIXM Financials SIXM Financials	SIXM −0,72%	635,59	−4,59	−0,72%	—	640,18	639,92	643,19	634,73	—	—
SIXR Staples SIXR Staples	SIXR −0,76%	843,15	−6,43	−0,76%	—	849,58	845,27	851,68	839,47	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,55%	216,29	−1,19	−0,55%	—	217,48	217,48	218,16	215,51	—	—
SIXT Technology SIXT Technology	SIXT +0,08%	3 263,41	+2,72	+0,08%	—	3 260,69	3 273,36	3 287,81	3 240,78	—	—
SIXU Utilities SIXU Utilities	SIXU −0,34%	939,24	−3,21	−0,34%	—	942,45	939,39	948,80	933,98	—	—
SIXV Health care SIXV Health care	SIXV −0,29%	1 462,56	−4,24	−0,29%	—	1 466,80	1 464,70	1 467,19	1 458,36	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,71%	2 380,40	−17,10	−0,71%	—	2 397,50	2 395,03	2 412,01	2 370,64	—	—

TNXP:NASDAQ

Tonix Pharmaceuticals Holding Corp

13,03 USD

−4,19%

(−0,57) 1 D

13,01 USD

−0,15% (−0,020)

Etter stengetid

Stengt: 4. mai, 16:00:00 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for TNXP …

Åpne

13,41 USD

Høy

14,09 USD

Lav

13,00 USD

Markedsverdi

185,10 mill.

Snittvolum

446,09k

Volum

0,00

52 u høy

69,97 USD

52 u lav

11,60 USD

EPS

−14,57 USD

Beta

1,68

Utestående aksjer

14,20 mill.

Antall ansatte

142

Relaterte aksjer

NRXP

NRX Pharmaceuticals Inc

Nyhetssaker

Fra kilder på nettet

MarketBeat

for 16 timer siden

Tonix Pharmaceuticals (TNXP) to Release Quarterly Earnings on Monday

Investing.com

for 21 timer siden

TD Cowen initiates Tonix Pharma stock with buy rating, $22 target

Stocktwits

for 2 døgn siden

TNXP Slips After Hours On Slower Than Expected Launch For Fibromyalgia Drug

Stock Titan

for 3 døgn siden

Tonix Pharmaceuticals (NASDAQ: TNXP) gives early look at Q1 2026 sales

Profil

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia

Om Tonix Pharmaceuticals Holding Corp

Administrerende direktørSeth Lederman

Ansatte142

Grunnlagt2007

HovedkontorChatham, New Jersey, USA

Sektor-

Nettstedtonixpharma.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	2,43 mill.	2,00 mill.	3,29 mill.	5,39 mill.
Varekostnad	943,00k	3,27 mill.	1,37 mill.	1,06 mill.
Direkte driftskostnader	943,00k	3,27 mill.	1,37 mill.	1,06 mill.
Utgifter til forskning og utvikling	7,44 mill.	10,82 mill.	9,29 mill.	16,94 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	10,10 mill.	16,20 mill.	25,70 mill.	35,68 mill.
Driftskostnader	17,54 mill.	27,02 mill.	34,99 mill.	52,62 mill.
Totale driftskostnader	18,48 mill.	30,29 mill.	36,36 mill.	53,68 mill.
Driftsinntekter	−16,05 mill.	−28,30 mill.	−33,07 mill.	−48,29 mill.
Andre ikke-operasjonelle inntekter	1,32 mill.	−919,00k	−174,00k	32,00k
EBT inkludert uvanlige elementer	−16,83 mill.	−28,27 mill.	−32,01 mill.	−46,91 mill.
EBT uten uvanlige elementer	−14,74 mill.	−28,27 mill.	−32,01 mill.	−46,91 mill.
Kostnad for inntektsskatt	-	-	-	-
Faktisk avgiftssats	-	-	-	-
Andre driftskostnader	-	-	-	-
Nettoinntekt	−16,83 mill.	−28,27 mill.	−32,01 mill.	−46,91 mill.
Netto fortjenestemargin	−692,84 %	−1 415,02 %	−972,95 %	−870,32 %
Resultat per aksje	−2,64	−4,00	−3,70	−3,98
Rente- og investeringsinntekter	-	943,00k	1,23 mill.	1,34 mill.
Rentekostnader	-	-	-	-
Netto rentekostnader	-	943,00k	1,23 mill.	1,34 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	−15,56 mill.	−27,81 mill.	−32,61 mill.	−47,80 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning